IGNACIO GARCIA DE LA TORRE

About IGNACIO GARCIA DE LA TORRE

IGNACIO GARCIA DE LA TORRE, With an exceptional h-index of 39 and a recent h-index of 27 (since 2020), a distinguished researcher at Universidad de Guadalajara, specializes in the field of Enfermedades Autoinmunes, Anticuerpos Antinuclares.

His recent articles reflect a diverse array of research interests and contributions to the field:

Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study

Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys

Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American …

AB0580 PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): DATA FROM A MULTIETHNIC, MULTINATIONAL LATIN AMERICAN COHORT

POS0169 PREDICTORS OF FIRST HOSPITALIZATIONS DUE TO DISEASE ACTIVITY AND INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY

Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys

IGNACIO GARCIA DE LA TORRE Information

University

Position

Profesor Investigador Titular "C" -

Citations(all)

7666

Citations(since 2020)

4257

Cited By

4582

hIndex(all)

39

hIndex(since 2020)

27

i10Index(all)

79

i10Index(since 2020)

48

Email

University Profile Page

Google Scholar

IGNACIO GARCIA DE LA TORRE Skills & Research Interests

Enfermedades Autoinmunes

Anticuerpos Antinuclares

Top articles of IGNACIO GARCIA DE LA TORRE

Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American …

Lupus

2024/2/9

AB0580 PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): DATA FROM A MULTIETHNIC, MULTINATIONAL LATIN AMERICAN COHORT

2023/6/1

POS0169 PREDICTORS OF FIRST HOSPITALIZATIONS DUE TO DISEASE ACTIVITY AND INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

2023/6/1

POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY

2023/6/1

Performance of the 2016 ACR-EULAR myositis response criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

Rheumatology

2023/11/1

Colonic adenocarcinoma an underlying malignancy of dermatomyositis: case report

International Journal of Research in Medical Sciences

2023/9

Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys

Rheumatology

2023/2/3

Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

Rheumatology

2023/7/1

Vaccine hesitancy among patients with idiopathic inflammatory myopathies and rheumatic diseases patients in 2021-2022: Covad survey

International Journal of Rheumatic Diseases

2023

COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a …

Clinical and Experimental Rheumatology

2023

Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP

Clinical Chemistry and Laboratory Medicine (CCLM)

2023/6/27

OP0082 COVID-19 VACCINE SAFETY DURING PREGNANCY AND BREASTFEEDING IN WOMEN WITH AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY

2023/6/1

See List of Professors in IGNACIO GARCIA DE LA TORRE University(Universidad de Guadalajara)